Revance Therapeutics, Inc. (RVNC)

3.65 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

RVNC Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $2.34 - $7.14
  • Market Capitalization: $379.98M
  • Short Percentage: 4.96%
  • Target Price: $9.47
  • Shares Outstanding: 104.39M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-24
Earnings

RVNC released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $11.75 Close: +10.04% Next Day: +14.04% Next Week: +28.94% View More
0 Comments Share
Help your fellow traders

Company Info

Stock Details

  • Current Price: $3.65
  • 52-Week Low: $2.34
  • 52-Week High: $7.14
  • Most Recent Quarter: 2024-09-30
  • Shares Float: 91.29M
  • Shares Outstanding: 104.39M
  • Market Capitalization: $379.98M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 4.96%

The short interest for Revance Therapeutics, Inc. is at 4.96%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 3.99%
Insiders: 8.56%
Instutitions: 87.45%

Analyst Target Price

9.47

Revance Therapeutics, Inc. is currently $5.82 below Wallstreet Analysts' price target.

Yesterday's Volume

4,122,950

Interest in Revance Therapeutics, Inc. has been trending up. The average daily volume in the past 14 days is 3,227,069.

Discussions

Please log in or register to share your thoughts.

wsb_pro11/6/24 03:03am

$RVNC the market is selling off

0 Like Report